Real-World Effectiveness and the Characteristics of a 'Super-Responder' to Mepolizumab in Severe Eosinophilic Asthma.
暂无分享,去创建一个
J. Kavanagh | J. Dhariwal | B. Kent | C. Roxas | L. Green | D. Jackson | M. Elstad | M. Fernandes | G. d'Ancona | A. Nanzer